Holen Sie sich die Stockscreener-App
3.30
8.91%
0.27
Schlusskurs vom Vortag:
$3.03
Offen:
$3.06
24-Stunden-Volumen:
1.96M
Relative Volume:
0.78
Marktkapitalisierung:
$229.64M
Einnahmen:
$151.64M
Nettoeinkommen (Verlust:
$-37.23M
KGV:
-6.0395
EPS:
-0.5464
Netto-Cashflow:
$-13.58M
1W Leistung:
+38.66%
1M Leistung:
+86.44%
6M Leistung:
+132.39%
1J Leistung:
-7.30%
1-Tages-Spanne:
$2.95
$3.305
1-Wochen-Bereich:
$1.99
$3.44
52-Wochen-Spanne:
$0.80
$3.80
Neuronetics Inc Stock (STIM) Company Profile
Firmenname
Neuronetics Inc
Sektor
Branche
Telefon
877-600-7555
Adresse
3222 PHOENIXVILLE PIKE, MALVERN, PA
Compare STIM vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STIM
Neuronetics Inc
|
3.30 | 223.38M | 151.64M | -37.23M | -13.58M | -0.5464 |
ABT
Abbott Laboratories
|
111.25 | 191.92B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
339.21 | 133.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
91.27 | 116.18B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
51.83 | 74.52B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
91.60 | 53.63B | 6.30B | 1.07B | 1.09B | 1.8406 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-13 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-10-13 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-10-13 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-01-22 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2020-02-06 | Eingeleitet | BTIG Research | Buy |
| 2018-07-24 | Eingeleitet | Canaccord Genuity | Buy |
Alle ansehen
Neuronetics Inc Aktie (STIM) Neueste Nachrichten
Point72 discloses 5% Neuronetics (STIM) stake in new SEC ownership filing - Stock Titan
US$6.00That's What Analysts Think Neuronetics, Inc. (NASDAQ:STIM) Is Worth After These Results - simplywall.st
Neuronetics, Inc. (STIM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Neuronetics earnings beat by $0.07, revenue topped estimates - Investing.com Nigeria
Neuronetics (STIM) Stock Repriced After Margin Gains And EBITDA Breakeven - Sahm
Neuronetics, Inc. (STIM) stock price, news, quote and history - Yahoo Finance Australia
Neuronetics, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Neuronetics Inc (STIM) (Q2 2026) Earnings Call Highlights: Reven - GuruFocus
Neuronetics Inc (STIM) (Q2 2026) Earnings Call Highlights: Revenue Growth and Margin Expansion ... - Yahoo Finance
Neuronetics (STIM) grows sales as going concern risk emerges under debt covenants - Stock Titan
STIM Maintained by BTIG -- Price Target Raised to $6.00 - GuruFocus
Neuronetics stock price target raised to $6 by BTIG on profitability - Investing.com Nigeria
Earnings call transcript: Neuronetics tops Q2 2026 forecasts as stock jumps 23% - Investing.com Canada
BTIG Research Forecasts Strong Price Appreciation for Neuronetics (NASDAQ:STIM) Stock - MarketBeat
Neuronetics Q2 2026 slides: mental health platform beats on margins By Investing.com - Investing.com Canada
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Neuronetics Q2 Earnings Call Highlights - MarketBeat
Neuronetics Narrows Q2 Loss as Greenbrook Growth Drives 9% Revenue Increase - Yahoo Finance
Why is Neuronetics stock surging today? By Investing.com - Investing.com Nigeria
Neuronetics (NASDAQ:STIM) Announces Earnings Results - MarketBeat
Why is Neuronetics stock surging today? - Investing.com
Neuronetics Q2 2026 slides: mental health platform beats on margins - Investing.com
Neuronetics publishes investor presentation on NeuroStar TMS, Greenbrook clinic network strategy - Bitget
Neuronetics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Neuronetics STIM Draws Buy Rating As Vertical Psychiatry Platform Scales Up - StocksToTrade
Form 8K Neuronetics Inc For: 11 August By Investing.com - Investing.com South Africa
Is Neuronetics Inc (STIM) Positioned for Growth After Q2 Earnings Miss? GF Score: 60/100 - GuruFocus
Neuronetics stock soars 15% on second quarter earnings beat By Investing.com - Investing.com South Africa
Neuronetics (STIM) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
STIM Looks 11.3% Overvalued on GF Value™ - GuruFocus
Q2 2026 Neuronetics Inc Earnings Call Transcript - GuruFocus
Neuronetics stock soars 15% on second quarter earnings beat - Investing.com
NEURONETICS ($STIM) Releases Q2 2026 Earnings - Quiver Quantitative
Neuronetics Q2 revenue beats estimates on Greenbrook clinic strength - TradingView
Neuronetics Reports Second Quarter 2026 Results, Highlights Revenue Growth and Improved Adjusted EBITDA - Quiver Quantitative
Neuronetics: Q2 Earnings Snapshot - KTVB
Press Release: Neuronetics Reports Second Quarter 2026 Financial and Operating Results - Moomoo
Neuronetics (STIM) Earnings Date and Reports 2026 $STIM - MarketBeat
Neuronetics Inc. (STIM) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Neuronetics Inc expected to post a loss of 12 cents a shareEarnings Preview - TradingView
Earnings Preview: Neuronetics to Report Financial Results Pre-market on August 11 - Moomoo
Jorey Chernett gains board input rights at Neuronetics (STIM) - Stock Titan
Neuronetics reaches accord with activist investor after sale pressure - The Business Journals
Neuronetics and Jorey Chernett Announce Shared Vision - The Manila Times
Weekly Recap: Q2 2026 results release and Rockville center opening - TradingView
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Neuronetics grants inducement RSUs to five new employees under 2020 incentive plan - Bitget
Neuronetics Announces Date for Second Quarter 2026 Financial and Operating Results Conference Call - Quiver Quantitative
Greenbrook Opens National Center of Excellence for Advanced Interventional Psychiatry in Rockville, Maryland - The Manila Times
Rockville Center Will Pilot Emerging Treatments Before Rollout - Stock Titan
Neuronetics to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call - marketscreener.com
Finanzdaten der Neuronetics Inc-Aktie (STIM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.08%
1.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):